{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:04:17Z","timestamp":1789949057501,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Accelerated atherosclerosis in older HIV-infected patients has been attributed to persistent immune activation and high burden cytomegalovirus (CMV), as demonstrated in transplant recipients and the general population. Here we assess CMV and inflammatory markers linked with vascular health in young adult patients treated in Indonesia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study design<\/jats:title><jats:p>HIV-infected adults (n\u2009=\u200932) were examined when they began antiretroviral therapy (ART) with\u2009&lt;\u2009200 CD4 T-cells\/\u00b5l (V0) and after 60\u00a0months (V60). Age-matched healthy controls (HC, n\u2009=\u200932) were assessed once.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Flow Mediated Dilatation (FMD) was assessed by ultrasound on brachial arteries at V60 and in HC. Plasma markers of immune activation and endothelial activation, and CMV antibodies (lysate, gB, IE-1) were assessed in all samples. Results were assessed using bivariate (non-parametric) and multivariable analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Levels of inflammatory biomarkers and CMV antibodies declined on ART, but the antibodies remained higher than in HC. FMD values were similar in patients and HC at V60. In HIV patients, levels of CMV lysate antibody correlated inversely (r\u2009=\u2009\u2212\u20090.37) with FMD. The optimal model predicting lower FMD values (adjusted R<jats:sup>2<\/jats:sup>\u2009=\u20090.214, p\u2009=\u20090.012) included CMV lysate antibodies and chondroitin sulphate. In HC, levels of sTNFR correlated inversely with FMD (r\u2009=\u2009\u2212\u20090.41) and remained as a risk factor in the optimal multivariable model, with CMV glycoprotein-B (gB) antibody predicting a healthier FMD (adjusted R<jats:sup>2<\/jats:sup>\u2009=\u20090.248, p\u2009=\u20090.013).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Higher levels CMV antibodies optimally predict vascular health measured by FMD in HIV patients. However in healthy controls, sTNFR marks risk and CMV gB antibody may be protective.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12981-021-00410-7","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T12:03:39Z","timestamp":1636632219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cytomegalovirus may influence vascular endothelial health in Indonesian HIV-infected patients after 5\u00a0years on ART"],"prefix":"10.1186","volume":"18","author":[{"given":"Ika Prasetya","family":"Wijaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birry","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Syahrir","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibnu","family":"Ariyanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Mansjoer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy","family":"Yunihastuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuntjoro","family":"Harimurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idrus","family":"Alwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-4451","authenticated-orcid":false,"given":"Patricia","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"410_CR1","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrcardio.2014.167","volume":"11","author":"MV Zanni","year":"2014","unstructured":"Zanni MV, Schouten J, Grinspoon SK, Reiss P. Risk of coronary heart disease in patients with HIV infection. Nat Rev Cardiol. 2014;11:728\u201341.","journal-title":"Nat Rev Cardiol"},{"key":"410_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2015.06.059","volume":"242","author":"D Sun","year":"2015","unstructured":"Sun D, Wu Y, Yuan Y, Wang Y, Liu W, Yang J. Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function. Atherosclerosis. 2015;242:109\u201316.","journal-title":"Atherosclerosis"},{"key":"410_CR3","doi-asserted-by":"publisher","DOI":"10.3791\/52070","author":"H Alley","year":"2014","unstructured":"Alley H, Owens CD, Gasper WJ, Grenon SM. Ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery in clinical research. J Vis Exp. 2014. https:\/\/doi.org\/10.3791\/52070.","journal-title":"J Vis Exp."},{"key":"410_CR4","doi-asserted-by":"publisher","first-page":"e1043","DOI":"10.1002\/cti2.1043","volume":"8","author":"S Lee","year":"2019","unstructured":"Lee S, Brook E, Affandi J, et al. A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population. Clin Transl Immunology. 2019;8:e1043.","journal-title":"Clin Transl Immunology."},{"issue":"1","key":"410_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12981-017-0180-9","volume":"14","author":"B Karim","year":"2017","unstructured":"Karim B, Wijaya IP, Rahmaniyah R, et al. Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART. AIDS Res Ther. 2017;14(1):52.","journal-title":"AIDS Res Ther"},{"key":"410_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1089\/vim.2018.0014","volume":"31","author":"IA Ariyanto","year":"2018","unstructured":"Ariyanto IA, Estiasari R, Waters S, et al. Active and persistent cytomegalovirus infections affect T Cells in young adult HIV patients commencing antiretroviral therapy. Viral Immunol. 2018;31:472\u20139.","journal-title":"Viral Immunol"},{"key":"410_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clim.2017.11.001","volume":"187","author":"S Waters","year":"2018","unstructured":"Waters S, Brook E, Lee S, Estiasari R, Ariyanto I, Price P. HIV patients, healthy aging and transplant recipients can reveal the hidden footprints of CMV. Clin Immunol. 2018;187:107\u201312.","journal-title":"Clin Immunol"},{"issue":"7","key":"410_CR8","doi-asserted-by":"crossref","first-page":"e005025","DOI":"10.1161\/JAHA.116.005025","volume":"6","author":"H Wang","year":"2017","unstructured":"Wang H, Peng G, Bai J, et al. Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): a meta-analysis of prospective studies up to 2016. J Am Heart Assoc. 2017;6(7):e005025.","journal-title":"J Am Heart Assoc."},{"key":"410_CR9","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1097\/QAD.0b013e3280108704","volume":"20","author":"PY Hsue","year":"2006","unstructured":"Hsue PY, Hunt PW, Sinclair E, et al. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS. 2006;20:2275\u201383.","journal-title":"AIDS"},{"key":"410_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/hiv.12672","volume":"20","author":"A Knudsen","year":"2019","unstructured":"Knudsen A, Kristoffersen US, Panum I, Hansen YB, Skottrup PD, Hasbak P, Kjaer A, Lebech AM. Coronary artery calcium and intima-media thickness are associated with level of cytomegalovirus immunoglobulin G in HIV-infected patients. HIV Med. 2019;20:60\u20132.","journal-title":"HIV Med"},{"key":"410_CR11","first-page":"195","volume":"85","author":"EAT Wulandari","year":"2020","unstructured":"Wulandari EAT, Wijaya IP, Karim B, et al. Periodontitis and cytomegalovirus associate with atherosclerosis among HIV patients after 5 years on ART. JAIDS. 2020;85:195\u2013200.","journal-title":"JAIDS"},{"key":"410_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/infdis\/jis276","volume":"205","author":"CM Parrinello","year":"2012","unstructured":"Parrinello CM, Sinclair E, Landay AL, et al. Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women. J Infect Dis. 2012;205:1788\u201396.","journal-title":"J Infect Dis"},{"key":"410_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1089\/aid.2006.0281","volume":"24","author":"ACO Andrade","year":"2008","unstructured":"Andrade ACO, Ladeia AM, Netto EM, et al. Cross-Sectional study of endothelial function in HIV-Infected patients in Brazil. AIDS Res Hum Retrovir. 2008;24:27\u201333.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"8","key":"410_CR14","doi-asserted-by":"publisher","first-page":"e0183511","DOI":"10.1371\/journal.pone.0183511","volume":"12","author":"A Dysangco","year":"2017","unstructured":"Dysangco A, Liu Z, Stein JH, Dub\u00e9 MP, Gupta SK. HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress. PLoS ONE. 2017;12(8):e0183511.","journal-title":"PLoS ONE."},{"key":"410_CR15","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1590\/S0102-311X2011001000013","volume":"27","author":"A Mariz Cde","year":"2011","unstructured":"Mariz Cde A, Albuquerque Mde F, Ximenes RA, et al. Body mass index in individuals with HIV infection and factors associated with thinness and overweight\/obesity. Cad Sa\u00fade P\u00fablica. 2011;27:1997\u20132008.","journal-title":"Cad Sa\u00fade P\u00fablica"},{"key":"410_CR16","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1128\/CVI.00020-11","volume":"18","author":"NF Crum-Cianflone","year":"2011","unstructured":"Crum-Cianflone NF, Roediger M, Eberly LE, et al. Impact of weight on immune cell counts among HIV-infected persons. Clin Vaccine Immunol. 2011;18:940\u20136.","journal-title":"Clin Vaccine Immunol"},{"key":"410_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3851\/IMP2651","volume":"18","author":"CO Hileman","year":"2013","unstructured":"Hileman CO, Carman TL, Longenecker CT, et al. Rate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort study. Antivir Ther. 2013;18:921\u20139.","journal-title":"Antivir Ther"},{"key":"410_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1054-3589(05)53013-8","volume":"53","author":"AD Theocharis","year":"2006","unstructured":"Theocharis AD, Tsolakis I, Tzanakakis GN, Karamanos NK. Chondroitin Sulfate as a key molecule in the development of atherosclerosis and cancer progression. Adv Pharm. 2006;53:281\u201395.","journal-title":"Adv Pharm"},{"key":"410_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/281284","volume":"2012","author":"E Zinellu","year":"2012","unstructured":"Zinellu E, Lepedda AJ, Cigliano A, et al. Association between human plasma chondroitin sulfate Isomers and carotid atherosclerotic plaques. Biochem Res Int. 2012;2012:1\u20136.","journal-title":"Biochem Res Int"},{"issue":"12","key":"410_CR20","doi-asserted-by":"publisher","first-page":"e004243","DOI":"10.1161\/JAHA.116.004243","volume":"5","author":"A Sinha","year":"2016","unstructured":"Sinha A, Ma Y, Scherzer R, Hur S, Li D, Ganz P, Deeks SG, Hsue PY. Role of T-cell dysfunction, inflammation, and coagulation in microvascular disease in HIV. J Am Heart Assoc. 2016;5(12):e004243.","journal-title":"J Am Heart Assoc."},{"key":"410_CR21","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/aid.2015.0328","volume":"32","author":"SJ Brunt","year":"2016","unstructured":"Brunt SJ, Cysique LA, Lee S, Burrows S, Brew BJ, Price P. Short communication: do cytomegalovirus antibody levels associate with age-related syndromes in HIV patients stable on antiretroviral therapy? AIDS Res Hum Retrovir. 2016;32:567\u201372.","journal-title":"AIDS Res Hum Retrovir"},{"key":"410_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25697","author":"JS Affandi","year":"2020","unstructured":"Affandi JS, Lee S, Chih HJ, et al. Cytomegalovirus burden improves a predictive model identifying measures of vascular risk in renal transplant recipients and healthy adults. J Med Virol. 2020. https:\/\/doi.org\/10.1002\/jmv.25697.","journal-title":"J Med Virol"},{"key":"410_CR23","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","volume":"377","author":"PD Griffiths","year":"2011","unstructured":"Griffiths PD, Stanton A, McCarrell E, et al. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet. 2011;377:1256\u201363.","journal-title":"Lancet"},{"key":"410_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3389\/fimmu.2013.00385","volume":"4","author":"BJ Connell","year":"2013","unstructured":"Connell BJ, Lortat-Jacob H. Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition. Front Immunol. 2013;4:385.","journal-title":"Front Immunol"},{"key":"410_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/icb.1995.47","volume":"73","author":"P Price","year":"1995","unstructured":"Price P, Allcock RJ, Coombe DR, Shellam GR, McCluskey J. MHC proteins and heparan sulphate proteoglycans regulate murine cytomegalovirus infection. Immunol Cell Biol. 1995;73:308\u201315.","journal-title":"Immunol Cell Biol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00410-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-021-00410-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-021-00410-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T23:29:29Z","timestamp":1673738969000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-021-00410-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["410"],"URL":"https:\/\/doi.org\/10.1186\/s12981-021-00410-7","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,11]]},"assertion":[{"value":"27 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is specified in materials and methods.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have provided consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors have competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}